SCHEMBL2480717

SCHEMBL2480717

CC(C)c1cc(-c2ccccc2)cc(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
MAPT P10636 4/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
SLC6A3 Q01959 1/20 0.42
SRD5A2 P31213 1/20 0.41
MEN1 O00255 2/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
JAK2 O60674 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
ALOX15 P16050 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL498198 0.84 MAPT (0.44) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2478197 0.84 MAPT (0.44) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2508951 0.82 MAPT (0.47) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2478858 0.82 KMT2A (0.45) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2481945 0.81 MAPT (0.48) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2509862 0.81 MAPT (0.50) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2508926 0.80 KMT2A (0.43) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2480096 0.80 PDCD1 (0.41) PDCD1CD274MAPTKMT2ASMN1; SMN2
SCHEMBL2481012 0.80 KMT2A (0.53) MAPTKMT2ASMN1; SMN2SLC6A3MEN1
SCHEMBL2882737 0.80 KMT2A (0.42) PDCD1CD274MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT PDCD1 699/4885CD274 1290/4885MAPT 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.